Regulation of cell fate and function by sterol homeostasis

Information

  • Research Project
  • 10004076
  • ApplicationId
    10004076
  • Core Project Number
    P20GM103620
  • Full Project Number
    5P20GM103620-08
  • Serial Number
    103620
  • FOA Number
    PAR-16-241
  • Sub Project Id
    6033
  • Project Start Date
    9/1/2013 - 11 years ago
  • Project End Date
    8/31/2023 - a year ago
  • Program Officer Name
  • Budget Start Date
    9/1/2020 - 4 years ago
  • Budget End Date
    8/31/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    08
  • Suffix
  • Award Notice Date
    9/9/2020 - 4 years ago
Organizations

Regulation of cell fate and function by sterol homeostasis

PROJECT SUMMARY Loss of cholesterol homeostasis has been associated with a host of neurodevelopmental and neurodegenerative disorders, though the precise mechanisms underlying cholesterol-mediated effects are unclear. While inherited mutations within cholesterol synthetic enzymes are known to induce neurodevelopmental deficits, the mechanisms behind cellular phenotypes resulting from these biochemical deficits remain largely undefined at the cellular and functional level. Therefore, studies delineating the role of cholesterol metabolism in neurodevelopment and function could have a significant impact on our understanding of potential common mechanisms of disease pathogenesis. Stem cell models exhibiting biochemical defects in the cholesterol synthetic pathway represent a novel biological model to study interactions between abnormal sterol levels and signaling events leading to cellular and functional deficits. Using induced pluripotent stem cell (iPSC) models exhibiting DHCR7 and SC5D mutations, we recently uncovered a unique regulatory role for sterol biosynthesis in the functional interactions between proteins mediating Wnt/?-catenin signaling. Within this proposal, we will test the hypothesis that defects in cholesterol synthesis inhibit normal neurodevelopment at the stem cell level through inhibition of protein-protein interactions, shifting differentiation patterns toward neuronal cell types at the expense of glial cells while inhibiting synaptic function. Aim 1 of this project will utilize genomic sequencing and functional studies in human iPSC derivatives and rodent models to define how defects in cholesterol homeostasis regulate neural specification and function. Aim 2 will correlate the cellular effects of altered cholesterol homeostasis with disrupted protein-protein interactions through biochemical analyses of protein-lipid interactions., In vivo cellular models will also define the kinetics, specificity, and downstream signaling events resulting from cholesterol defects. These experiments will significantly advance our understanding of the role of cholesterol and associated signaling in regulating neurodevelopment and neuronal function, while potentially elucidating the mechanistic underpinnings of cholesterol homeostatic changes in common neurological diseases.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    186718
  • Indirect Cost Amount
    119484
  • Total Cost
  • Sub Project Total Cost
    306202
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIGMS:306202\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SANFORD RESEARCH/USD
  • Organization Department
  • Organization DUNS
    050113252
  • Organization City
    SIOUX FALLS
  • Organization State
    SD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    571040569
  • Organization District
    UNITED STATES